BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3145343)

  • 1. [Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
    Shiritani Y; Yamaji S; Aoki A; Saigusa M; Yokoiyama S; Gato S; Tsuji A
    Jpn J Antibiot; 1988 Nov; 41(11):1591-9. PubMed ID: 3145343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa].
    Sato K; Yamashita K; Okachi R
    Jpn J Antibiot; 1986 Jun; 39(6):1487-93. PubMed ID: 3093728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
    Kumagai K; Otsuki H; Nishibuchi M; Takeda Y
    Jpn J Antibiot; 1990 Sep; 43(9):1579-87. PubMed ID: 2124634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activity of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo.
    Kitaura K; Mineura K; Nakamizo N; Shiba K; Ohmori M; Saito A; Ueda Y
    J Antibiot (Tokyo); 1984 Dec; 37(12):1681-6. PubMed ID: 6441792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
    Yamashiro Y; Ogake N; Takahata M; Minami S
    Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 3. The results against Pseudomonas aeruginosa].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1996 May; 49(5):509-16. PubMed ID: 8752864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of dosing regimens and combination effects of aminoglycosides and beta-lactam in an experimental Pseudomonas aeruginosa infection in mice].
    Kikuchi K
    Kansenshogaku Zasshi; 1991 Feb; 65(2):216-25. PubMed ID: 2066605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro interaction of tazobactam/piperacillin combined with aminoglycosides against Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli AND Staphylococcus aureus].
    Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Feb; 55(1):61-6. PubMed ID: 11977921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of isepamicin and beta-lactam antibiotics on the release of endotoxin from Pseudomonas aeruginosa].
    Yamaguchi S; Sato S; Toriya M; Tsuji A
    Jpn J Antibiot; 1999 Jan; 52(1):41-56. PubMed ID: 10202687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
    Nishida K; Higashitani F; Hyodo A
    Chemotherapy; 1997; 43(3):171-8. PubMed ID: 9142457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of synergistic enhancement of antimicrobial activities of piperacillin and amikacin against Pseudomonas aeruginosa using FIC index and disc diffusion method].
    Uete T; Matsuo K
    Jpn J Antibiot; 1990 Sep; 43(9):1572-8. PubMed ID: 2124633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bactericidal effects and combined action of micronomicin with beta-lactam antibiotics against Pseudomonas aeruginosa and Escherichia coli].
    Yamashita K; Minagawa H; Sato K; Kitaura K; Okachi R
    Jpn J Antibiot; 1983 Jan; 36(1):189-93. PubMed ID: 6221129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the combination action of sisomicin, gentamicin and piperacillin, cefmetazole against Pseudomonas aeruginosa and Serratia marcescens].
    Saito M; Shibata K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Jan; 36(1):37-46. PubMed ID: 6221130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-antibiotic effect induced by an antibiotic combination: influence of altered susceptibility to individual components.
    Li RC; Tang MC
    J Antimicrob Chemother; 2005 Apr; 55(4):583-6. PubMed ID: 15728143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro combination effect of pazufloxacin with various antibiotics against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus].
    Maekawa M; Takahashi K; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):440-5. PubMed ID: 12378872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro combination effects of astromicin and beta-lactam antibiotics against CFS-sensitive and CFS-resistant Pseudomonas aeruginosa. In vitro synergistic activity].
    Yamada H; Takeyama H; Watanabe E; Fukutani H; Saka Y; Suzuki K; Kameyama Y; Esaki J; Yamazaki H; Mori Y
    Jpn J Antibiot; 1988 May; 41(5):478-84. PubMed ID: 3145991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic efficacy of cefodizime in combination with aminoglycosides against systemic infections caused by Pseudomonas aeruginosa in immunocompromised tumour bearing mice].
    Furukawa T; Uji T; Miyake Y; Hyodo A; Deguchi K
    Jpn J Antibiot; 1993 Jun; 46(6):472-81. PubMed ID: 8360982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.
    Gerber AU; Feller C; Brugger HP
    Eur J Clin Microbiol; 1984 Dec; 3(6):592-7. PubMed ID: 6098475
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination antibacterial effects between aztreonam and eight other antibiotics].
    Nishino T; Obana Y; Kuzui H; Murakami T
    Jpn J Antibiot; 1991 Jan; 44(1):1-8. PubMed ID: 1904106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.